NEW YORK, Sept. 7, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Bed Bath & Beyond Inc. (“Bed Bath & Beyond” or the “Company”) (NASDAQ: BBBY).

If you have purchased or otherwise acquired bed bath beyond common shares in between March 25, 2022 and August 18, 2022inclusive (the “Class Period”) and would like to discuss our investigation, please contact us via email [email protected] or by calling (646) 315-9003.

If you are a member of the proposed class, you can move the court by October 24, 2022 at the latest to serve as lead plaintiff for the alleged class. You do not have to seek lead plaintiff to participate in a possible recovery.

On Sunday, March 6, 2022, Ryan Cohen (“Cohen”) sent a letter to the Board of Directors of Bed Bath & Beyond disclosing that his investment firm, RC Ventures LLC, acquired a 9.8% interest in Bed Bath & Beyond owns. Cohen’s letter also criticized management for “disappointing shareholder returns and continued underperformance” and put forward proposals to improve shareholder returns. Following this news, on Monday, March 7th, 2022, shares of Bed Bath & Beyond rose 34% on heavy trading volume to close at $21.71 per share.

On August 16, 2022, RC Ventures LLC filed a Schedule 13D with the SEC stating, “[a]As of the date of this document, RC Ventures directly beneficially owned 9,450,100 shares, including 1,670,100 shares underlying certain call options, representing approximately 11.8% of the outstanding shares.” According to the complaint, the filing disclosed also that Cohen had held April call options through RC Ventures that would not pay out until the stock reached $60 per share before Jan. 23, 2023. Beyond Shares closed 29% higher on August 16, 2022 compared to the previous close due to heavy trading volume and closed at $20.65 per share.

Then, on August 18, 2022, through his investment, Cohen…